Mr. Speaker, I agree with quite a number of the member's comments. With CETA, there were many components that the New Democrats were concerned about. The investor-state dispute settlement provisions were certainly one of them. The issue around the increased cost of drugs related to additional patent protections for pharmaceuticals was another. Restrictions on local content provisions for subnational procurement initiatives was a third element. Then, of course, the concessions resulting in lost market share for Canadian dairy products were also a component we were very concerned about. These are just some highlights.
The real question is this: Why would the government proceed with this transitional agreement without a sunset clause?